Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:50 pm Unchanged | 2024-09-30 | 13G | XILIO THERAPEUTICS INC XLO | Rock Springs Capital Management LP | 214,518 6.830% | 0 (Unchanged) | Filing History |
| 2024-11-12 10:40 am Sale | 2024-11-08 | 13G | XILIO THERAPEUTICS INC XLO | FMR LLC | 99,704 3.175% | -36,558 (-26.83%) | Filing History |
| 2024-09-27 9:36 pm Purchase | 2024-06-07 | 13G | XILIO THERAPEUTICS INC XLO | GKCC, LLC | 500,000 15.900% | 500,000 (New Position) | Filing History |
| 2024-07-31 07:46 am Unchanged | 2024-07-31 | 13G | XILIO THERAPEUTICS INC XLO | TAKEDA PHARMACEUTICAL CO LTD TAK | 105,366 4.000% | 0 (Unchanged) | Filing History |
| 2024-04-05 4:31 pm Purchase | 2024-03-27 | 13G | XILIO THERAPEUTICS INC XLO | GILEAD SCIENCES INC. GILD | 524,677 19.900% | 524,677 (New Position) | Filing History |
| 2024-04-05 2:51 pm Purchase | 2024-03-27 | 13G | XILIO THERAPEUTICS INC XLO | Rock Springs Capital Management LP | 214,518 8.710% | 111,607 (+108.45%) | Filing History |
| 2024-02-14 2:12 pm Sale | 2023-12-31 | 13G | COMPASS THERAPEUTICS INC CMPX | Rock Springs Capital Management LP | 1,440,759 5.230% | -3,892,429 (-72.99%) | Filing History |
| 2024-02-06 4:04 pm Sale | 2024-01-02 | 13G | XILIO THERAPEUTICS INC XLO | Octagon Capital Advisors LP | 0 0.000% | -127,500 (Position Closed) | Filing History |
| 2024-02-05 4:01 pm Sale | 2023-12-31 | 13G | XILIO THERAPEUTICS INC XLO | Octagon Capital Advisors LP | 127,500 6.480% | -45,714 (-26.39%) | Filing History |
| 2023-04-10 4:57 pm Purchase | 2023-03-30 | 13G | XILIO THERAPEUTICS INC XLO | MRL Ventures Fund LLC | 105,958 5.400% | 105,958 (New Position) | Filing History |
| 2023-02-09 08:14 am Sale | 2023-02-09 | 13G | XILIO THERAPEUTICS INC XLO | FMR LLC | 136,262 6.944% | -47,329 (-25.78%) | Filing History |
| 2023-01-25 4:01 pm Purchase | 2022-12-31 | 13G | XILIO THERAPEUTICS INC XLO | Octagon Capital Advisors LP | 173,214 8.830% | 173,214 (New Position) | Filing History |
| 2022-12-29 5:24 pm Sale | 2022-12-29 | 13G | XILIO THERAPEUTICS INC XLO | Deerfield Management Company, L.P. | 0 0.000% | -153,861 (Position Closed) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | XILIO THERAPEUTICS INC XLO | RA Capital Management, L.P. | 0 0.000% | -143,015 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | RA Capital Management, L.P. | 143,015 7.300% | 33,532 (+30.63%) | Filing History |
| 2022-02-14 06:42 am Unchanged | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | BCLS II Equity Opportunities, LP | 96,334 4.900% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:14 pm Sale | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | Deerfield Management Company, L.P. | 153,861 7.840% | -9,564 (-5.85%) | Filing History |
| 2022-02-09 10:04 am Sale | 2022-02-08 | 13G | XILIO THERAPEUTICS INC XLO | FMR LLC | 183,591 9.357% | -6,243 (-3.29%) | Filing History |
| 2022-01-14 06:07 am Purchase | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | TAKEDA PHARMACEUTICAL CO LTD TAK | 105,366 5.370% | 105,366 (New Position) | Filing History |
| 2021-11-05 5:16 pm Purchase | 2021-10-26 | 13G | XILIO THERAPEUTICS INC XLO | BCLS II Equity Opportunities, LP | 96,334 5.100% | 96,334 (New Position) | Filing History |